Pharmaceutical drug development relies heavily on the creation of amorphous solid dispersions (ASDs) to enhance the dissolution rate and stability of active pharmaceutical ingredients (APIs). Developing ASDs with the desired physico-chemical properties is a complex and time-consuming process that often involves the manual preparation of numerous sample compositions with varying ratios of API and excipients.
Click here for original story, Automating pharmaceutical spray drying for accelerated drug development
Source: Phys.org